The Clinical Times
The Front Page of Medicine

Latest medical news · page 33

The latest headlines across every section, pulled from official and open-access sources.

Annals of Family Medicine · Jul 27, 2026

Im Still Standing: Highs, Lows, and Lessons Learned From Menieres Disease

Ménière’s disease, a chronic disorder of the inner ear, has brought one physician a great deal of both suffering and insight. A variety of treatment options, including dietary changes and medications, have failed to help. However, the physician has found relief from a number of unexpected sources, including meditation, his social support network, and even his six-year-old child. The lessons he has learned have made him a more knowledgeable and empathetic physician. Abstract available in عربي ( Arabic ); Deutsch ( German ); Español ( Spanish ); Francais ( French ); हिन्ी ( Hindi )…

Annals of Family Medicine · Jul 27, 2026

Continuity at the Incision: Why Cesarean Delivery Belongs in Family Medicine

As obstetric services disappear from rural communities, family physicians are increasingly asked whether operative maternity care remains part of their role. This reflection argues that maintaining cesarean delivery capacity is not an expansion of scope, but a commitment to continuity and to remaining present for patients at moments of greatest vulnerability. Drawing on rural clinical experience, this essay explores how trust, built over time, extends into the operating room, where continuity takes on a different but no less essential form. It also considers the ethical implications of…

ACC (Cardiology) · Jul 27, 2026

CKM Syndrome Associated With Increased, Stage-Specific Cancer Risk

Cardiovascular-kidney-metabolic (CKM) syndrome is associated with incremental cancer risk and stage-specific immune-metabolic pathways, according to a study using data from the UK Biobank published July 16 in JACC: CardioOncology. These findings highlight potential prevention targets.

MedTech Dive · Jul 27, 2026

Freenome secures FDA nod for blood-based colorectal cancer test

Abbott will market Freenome’s SimpleScreen CRC test in the U.S., alongside its Cologuard stool test. SimpleScreen will compete with Guardant Health’s Shield blood test for colorectal cancer screening.

FDA Drugs · Jul 27, 2026

Electronic Registration and Listing Compliance Program

Establishment registration and drug listing data is submitted by drug manufacturers and own label drug distributors through electronic means using Structured Product Labeling format (SPL).

ACC (Cardiology) · Jul 27, 2026

If You Build It, Will They Come? Digital Health in AF Management

Atrial fibrillation (AF) is the most common sustained arrhythmia in the United States, with a nation-wide prevalence projected to reach 12.1 million by 2030.1 AF is a major driver of adverse clinical outcomes, including stroke, dementia, myocardial infarction, sudden cardiac death, heart failure, chronic kidney disease, and all-cause death.

FDA Drugs · Jul 27, 2026

CDER Patient-Focused Drug Development

Patient-focused drug development (PFDD) is a systematic approach to help ensure that patients’ experiences, perspectives, needs, and priorities are captured and meaningfully incorporated into drug development and evaluation. The primary goal of patient-focused drug development is to better incorpora

WHO · Jul 27, 2026

WHO: Integration, innovation and community leadership key to ending HIV, hepatitis and STIs

The World Health Organization (WHO) today launched a new report assessing progress in implementing the Global Health Sector Strategies (GHSS) on HIV, viral hepatitis and sexually transmitted infections (STIs) for 2022–2030. Released during the 26th International AIDS Conference (AIDS 2026) and ahead of World Hepatitis Day (28 July), the report highlights significant achievements and persistent challenges in the global response to these epidemics.

MedTech Dive · Jul 27, 2026

Why Aidoc is taking a generative AI device to the FDA

Aidoc is bringing a system that can interpret images and make draft reports for radiologists to the FDA as the medtech industry awaits clarity on regulation of generative AI. Ensuring safety is paramount, said CEO Elad Walach.

PLOS Medicine · Jul 27, 2026

The cancer survivorship paradox in the digital era

by Josephine Hegarty, Ismail Toygar, Maria Inês Clara, Ewa Pawlowska Many assumptions around patient needs and support guide current oncology practice and cancer survivorship care in the digital era. Addressing these assumptions and providing smarter, holistic, tech-enabled follow-up models are essential for truly effective and sustainable person-centered care.

MedCity News · Jul 27, 2026

Prior Authorization Is Draining Revenue: Why Automation Has Become a Strategic Imperative

When staff are overextended and patients face delays or abandon care, the issue is no longer a narrow administrative burden. It becomes a business, financial, and access challenge that demands a different operating model. The post Prior Authorization Is Draining Revenue: Why Automation Has Become a Strategic Imperative appeared first on MedCity News .

MedCity News · Jul 27, 2026

How AI Inside Clinical Workflows Is Unlocking Patient Throughput

The question is not whether the technology is impressive. The question is whether it shows up at the right time, with the right information, inside the workflow where the decision is being made. Anything else is just another report. The post How AI Inside Clinical Workflows Is Unlocking Patient Throughput appeared first on MedCity News .

BMJ Open · Jul 27, 2026

Diabetes Priorities Questionnaire (DPQ): a codesigned preclinic priority setting tool to enable patient-centred care for people with type 2 diabetes

Objective To codesign a preclinic Diabetes Priorities Questionnaire (DPQ) tool for people with type 2 diabetes and healthcare professionals to identify patient needs in advance and enable efficient, patient-centred consultations for diabetes management. Design Participatory approach using codesign focus groups to explore perspectives and develop solutions. Setting This study was conducted in Western Sydney, Australia, an area with high socioeconomic disadvantage and cultural diversity. Participants 10 adults with type 2 diabetes and 8 healthcare providers including specialists, diabetes…

← NewerOlder →

Back to the live front page